Louisiana State University Health Sciences Center

Louisiana State University Health Sciences Center is a U.S. government entity registered to receive federal awards since February 1, 2002. It is classified as a U.S. state government organization, non-profit organization, educational institution, and state-controlled institution of higher learning. The center has a history of receiving both federal contract and grant awards, with its most recent federal contract award on September 16, 2005, and its most recent federal grant award on May 1, 2014. As a health sciences center within the Louisiana State University system, it likely provides medical education, research, and healthcare services to the state of Louisiana and contributes to advancing medical knowledge and practices through its federally funded work.

Louisiana State University Health Sciences Center has been involved in several federally funded research projects as a sub-grantee, focusing on critical areas of medical research, particularly in the field of infectious diseases and immunology. One such project, funded through Emory University, involves the development of novel nanoparticulate adjuvants to enhance HIV-1 ENV-specific mucosal antibody responses. Another sub-grant, with Oregon Health & Science University as the prime grantee, studies human cytomegalovirus dysregulation of host hematopoietic progenitor cell signaling pathways and its effects on latency, reactivation, and hematopoiesis. Additionally, the center participates in research on B and T cell biology related to protection from and eradication of SIV/SHIV infection, also in collaboration with Emory University. These sub-grants suggest that the center's work is primarily funded by federal health agencies, likely including the National Institutes of Health, and contributes significantly to advancing understanding and treatment of viral infections and immune system responses.